Shive was a graduate scholar in the NCI molecular pathology GPP in partnership with the University of Maryland and the National Cancer Institute, from 2006 to 2010.
Dr. Shive received her B.S. from the University of Arizona and her D.V.M from North Carolina State University, College of Veterinary Medicine in 2004. Following graduation, she joined the residency program in anatomic pathology in the Department of Pathobiology at Texas A&M University, College of Veterinary Medicine, wehre she trained for two years. She was accepted as a graduate fellow in molecular pathology through the Graduate Partnership Program (GPP) at the National Cancer Institute in 2006. While pursuing graduate training at the NCI, she achieved board certification in Anatomic Pathology by the American College of Veterinary Pathologists in 2007. Dr. Shive completed her dissertation research in the research laboratory of Dennis Hickstein, M.D., in the Experimental Transplantation and Immunology Branch at the NCI. The dissertation project was focused on investigating germline mutations in the breast cancer-2 gene (brca2) in the zebrafish (Danio rerio). These studies revealed a critical role for brca2 in ovarian development, and provide new insights into brca2 mutation and cancer susceptibility. Members of her graduate guidance committee included: Siba Samal, BVSc, Ph.D., Diplomate, The American College of Veterinary Microbiologists (chair); Dennis Hickstein, M.D.; Paul Liu, M.D., Ph.D. (NHGRI); Mark Simpson, D.V.M, Ph.D., Diplomate, The American College of Veterinary Pathologists; Liangli Yu, Ph.D. and Xiaoping Zhu, D.V.M, Ph.D. After receiving her Ph.D. in 2010, Dr. Shive accepted a Staff Scientist position in the NCI, CCR, Transplantation and Immunology Branch, where she continued her cancer research using the zebrafish model. She served as an assistant professor at North Carolina State University, Raleigh, NC for several years before moving to Ohio State University, Columbus, Ohio.
